Successful discontinuation rate · participants with depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Successful discontinuation rate · participants with depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality within the longest · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in all‐cause mortality (at longest compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
All‐cause mortality (up to 30 days) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in all‐cause mortality (up to 30 days) compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Blood loss requiring transfusion of blood products (intraoperatively and postoperatively) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in blood loss requiring transfusion of blood products (intraoperatively… compared with discontinuation of antiplatelet therapy (moderate certainty).
1 finding from 1 review
Blood loss requiring further surgery (intraoperatively and postoperatively) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in blood loss requiring further surgery (intraoperatively and… compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Ischaemic events: peripheral thrombosis, cerebral myocardial infarction (within 30 days of surgery) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in ischaemic events: peripheral thrombosis, cerebral myocardial… compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Successful discontinuation rate · participants with long‐term antidepressants for depressive disorders
1 finding from 1 review
Success of withdrawal from antipsychotics · older people with dementia who had been taking an antipsychotic drug for at least 3 months
Discontinuation may leads to lower success of withdrawal from antipsychotics compared with continuation of antipsychotic medication (low certainty).
1 finding from 1 review
Behavioural and psychological symptoms · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
Adverse events · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
QoL · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
Cognitive function · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
Use of physical restraints · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
All‐cause mortality · older people with dementia who had been taking an antipsychotic drug for at least 3 months
1 finding from 1 review
Successful discontinuation rate · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Relapse · participants with depressive or anxiety disorders
It is very uncertain whether abrupt discontinuation changes relapse (as defined by study authors) (HR) compared with continuation of long‐term antidepressants (very low certainty).
1 finding from 1 review
Withdrawal symptoms · participants with depressive or anxiety disorders
1 finding from 1 review
Adverse events · participants with depressive or anxiety disorders
It is very uncertain whether abrupt discontinuation changes adverse events compared with continuation of long‐term antidepressants (very low certainty).
1 finding from 1 review
Depressive symptoms · participants with depressive or anxiety disorders
1 finding from 1 review